Showing results (2301-2310 of 2,503) with videos related to
Sort By:
Pageof 251
Journal of the American College of Cardiology|February 9, 2013
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)Manesh R Patel, Anne S Hellkamp, Yuliya Lokhnygina, et al.Thrombosis and Haemostasis|March 17, 2017
Whole exome sequencing in the Framingham Heart Study identifies rare variation in HYAL2 that influences platelet aggregationJohn D Eicher, Ming-Huei Chen, Achilleas N Pitsillides, et al.Stroke|April 19, 2014
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillationGraeme J Hankey, Susanna R Stevens, Jonathan P Piccini, et al.European Heart Journal|August 4, 2012
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trialThomas J Povsic, John P Vavalle, Laura H Aberle, et al.Blood Advances|February 8, 2022
G6b-B regulates an essential step in megakaryocyte maturationIsabelle C Becker, Zoltan Nagy, Georgi Manukjan, et al.Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic PainJessica S Merlin, Dustin Long, William C Becker, et al.Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experienceKenneth W Mahaffey, Anne S Hellkamp, Manesh R Patel, et al.Journal of Cardiology|August 14, 2023
Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?Mark H Eckman, Ruth Wise, Carol Knochelmann, et al.European Heart Journal|September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF TrialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.Pageof 251